Obesity

Weight Management Weight Loss Treatment Options Weight Loss Treatments Health Risks Medications Causes Childhood Obesity Treatment Weight Loss Drugs Body Mass Index Diabetes Chronic Diseases Chronic Conditions BMI Diagnosis Obesity Treatment Causes of Obesity Metabolic Health Risk Factors Public Health Genetics Type 2 Diabetes Obesity Drugs Obesity Rates Weight Loss Medications Obesity Management Body Composition Pediatric Obesity Complications of Obesity GLP-1 Agonists Weight Loss Methods Metabolic Disorders Severe Obesity Anti-Obesity Drugs Weight Loss Strategies Global Health Crisis Prevalence Weight-Related Conditions Economic Impact Stigma Lifestyle Diseases Weight Loss Medication Obesity Treatments Clinical Trials Health Conditions Mental Health BMI Limitations Weight-Loss Treatments Dietary Habits Prevention Visceral Fat Weight Loss Surgery Weight-loss Drugs Weight Regain Pharmaceuticals Politics Body Fat Measurement Clinical Obesity Lifestyle Factors Classification Incretin-based Drugs Weight Gain Behavioral Science Animal Health Obesity Pandemic Cardiovascular Diseases Metabolism Genetic Factors Body Mass Index (BMI) Dietary Impact on Weight ACA Marketplace Plans Diet and Lifestyle GLP-1s Life Expectancy Statistics Health Issues GLP-1 Class Drugs Public Health Efforts Overweight Adults Societal Impact Biological Mechanisms Epidemiology Body Acceptance Movement Comprehensive approach Surgery Cancer Types Food Industry Responsibility Disease Obesity-related Heart Conditions Weight-Loss Market Health risks Heart Health Weight Management Medications Associated Diseases Medical Benefits Weight Loss Statistics Diseases Gut Health Treatment for Obesity

UK to Pilot Pharmacy-Based Access to Weight Loss Jabs for £9.90 NHS Fee

Government plans trials allowing pharmacies to dispense GLP-1 weight loss injections after brief consultations, aiming to improve affordability and accessibility.

British Heart Foundation Unveils Practical Sugar-Reduction Swaps for Healthier Diets

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

Study Links High-Fat, High-Sugar Diets to Memory and Navigation Deficits in Young Adults

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

High-Fat, High-Sugar Diets Impair Young Adults’ Memory and Navigation, Study Shows

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Canada Updates Pediatric Obesity Guidelines for First Time in 20 Years

Prepregnancy Obesity Linked to Higher Midlife Cardiovascular Risks

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

WeightWatchers Prepares for Bankruptcy as Weight Loss Drug Demand Surges

Study Links Colder Conception Months to Improved Metabolic Health

CMS Rejects Medicare and Medicaid Coverage for Anti-Obesity Drugs

New Study Links Sucralose to Increased Hunger and Altered Brain Activity

Intermittent fasting found to outperform daily calorie restriction for weight loss

Florida Death Row Inmate Seeks Stay of Execution Over Health Risks

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Study Links Midlife Diet and Waist-to-Hip Ratio to Long-Term Brain Health

Study Finds Married Men More Prone to Weight Gain Than Singles

Turkish Mukbang Star Efecan Kultur Dies at 24 from Obesity-Related Complications

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Study Links Obesity Gene in Labradors to Human Weight Gain

Global Obesity Crisis Projected to Impact 60% of Adults by 2050

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

PM Modi Advocates Science Exploration and Women Empowerment in Latest Mann Ki Baat

Star Jones Reflects on Life-Saving Open-Heart Surgery and Health Advocacy

Experts Warn Against Discounted Weight Loss Surgeries Abroad

Study Uncovers Neural Circuit Behind Sugar Cravings After Full Meals

Scientists Uncover Brain Mechanism Behind Post-Meal Cravings for Sweets

Bodybuilding Champion Suel Nogueira Dies in Motorcycle Accident at 40

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

Oprah Winfrey Reflects on Weight Loss Drugs and Misconceptions About Thin People

Experts Call for Overhaul of Obesity Diagnosis Standards

Global Experts Redefine Obesity with New Diagnostic Criteria

Experts Call for Overhaul of Obesity Diagnosis Methods

Experts Call for Overhaul of Obesity Diagnostic Criteria

Gut Bacteria Linked to Reduced Cravings for Sugar

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

Man Loses 27 Kg in 4 Months Following Simple Fat-Loss Diet

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns

Study Identifies Optimal Exercise Duration for Weight Loss

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

Nestle Introduces Protein Shot to Support Weight Loss and Hunger Management

Brain Enzyme Inhibition Shows Promise for Obesity Treatment

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

U.S. Predicted to Drop Sharply in Global Life Expectancy Rankings by 2050

Experts Urge Broader Approach to Obesity Beyond GLP-1 Drugs

Ultra-Processed Foods Linked to Increased Fat in Thigh Muscles, Study Finds

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

France Approves Reimbursement for Anti-Obesity Drug Wegovy

MIT Develops Inflatable Gastric Balloon for Dynamic Appetite Control

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

Diabetes and Obesity Drugs Found to Protect Kidney Health

Trump Nominates Dr. Marty Makary as FDA Commissioner

Novo Nordisk Launches Wegovy in China at Lower Price Point

New Study Reveals Fat Cells' Memory of Obesity

GLP-1 Medications See Surge in Use for Weight Loss and Potential Addiction Treatment

White Sox Appoint Ryan Fuller as Director of Hitting

New Weight Loss Drug Shows Promise Without Nausea

Genetic Mutation Linked to Reduced Sugar Cravings

Novo Nordisk's Weight-Loss Drugs Boost Danish Economy Amid Local Health Challenges

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

Ancient Gene Duplication Enhanced Human Starch Digestion

UK Government Trials Weight-Loss Jabs to Tackle Unemployment

Ozempic Shows Promising Mental Health and Cognitive Benefits

Study Links COVID-19 in Kids to Increased Type 2 Diabetes Risk

Study Links Weight Loss Drugs to Reduced Suicide Risk in Obese Teens

FDA Reconsiders Ban on Compounded Versions of Eli Lilly's Weight Loss Drug

Gut Hormones Offer New Hope in Combating Fatty Liver Disease

Study Reveals Baby Boomers Face Greater Health Challenges Than Predecessors

Reducing Sitting Time and Increasing Activity Can Help Manage Back Pain

WeightWatchers CEO Sima Sistani Steps Down Amid Struggles with Weight-Loss Drugs

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Long-Term Exercise Alters Belly Fat to Be Healthier, Study Finds

Weight Loss Drug Liraglutide Shows Promise for Children as Young as Six

Night Owls Face Significantly Higher Risk of Type 2 Diabetes

Compounded Weight Loss Drugs Raise Safety and Ethical Concerns

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Soup and Shake Diet Shows Promise in Reversing Type 2 Diabetes

Cancer Rates Surge in Gen X and Millennials

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients

Roche's New Weight Loss Pill Shakes Up Pharmaceutical Market

Scientists Convert White Fat Cells to Calorie-Burning Beige Fat

Michigan's Largest Insurer Ends Coverage for Costly Weight-Loss Drugs

Evening Exercise Significantly Reduces Blood Sugar Levels in Overweight Adults

Gospel Singer Mandisa Dies at 47 Due to Complications from Obesity

Decade-Long Obesity Significantly Increases Heart Attack and Stroke Risk

New Study Shows Ozempic and Wegovy Enhance Taste Sensitivity in Women

Intermittent Fasting and Protein Pacing Boost Gut Health and Weight Loss